BR0314781A - Composição de polìmero e formas de dosagem compreendendo a mesma - Google Patents

Composição de polìmero e formas de dosagem compreendendo a mesma

Info

Publication number
BR0314781A
BR0314781A BR0314781-9A BR0314781A BR0314781A BR 0314781 A BR0314781 A BR 0314781A BR 0314781 A BR0314781 A BR 0314781A BR 0314781 A BR0314781 A BR 0314781A
Authority
BR
Brazil
Prior art keywords
same
dosage forms
polymer composition
composition
dosage form
Prior art date
Application number
BR0314781-9A
Other languages
English (en)
Inventor
Jen Chi Chen
Frank J Bunick
Harry S Sowden
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/031163 external-priority patent/WO2003026627A1/en
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Priority claimed from PCT/US2003/008960 external-priority patent/WO2004028514A1/en
Publication of BR0314781A publication Critical patent/BR0314781A/pt

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO DE POLìMERO E FORMAS DE DOSAGEM COMPREENDENDO A MESMA". é fornecida uma composição compreendendo um polímero solúvel em água de peso molecular elevado, tendo um ponto de turvamento de cerca de 20 a cerca de 90<198>C e um polímero de gelificação. A composição pode ser empregada como um componente de uma forma de dosagem farmacêutica, tal como a casca de uma forma de dosagem, ou como uma matriz comestível, isto é, uma forma de dosagem farmacêutica de per si.
BR0314781-9A 2002-09-28 2003-03-21 Composição de polìmero e formas de dosagem compreendendo a mesma BR0314781A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/US2002/031163 WO2003026627A1 (en) 2001-09-28 2002-09-28 Composite dosage forms
PCT/US2002/031024 WO2003026625A1 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031129 WO2003026630A1 (en) 2001-09-28 2002-09-28 Dosage forms having an inner core and outer shell with different shapes
PCT/US2002/031062 WO2003026626A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031117 WO2003026629A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2003/008960 WO2004028514A1 (en) 2002-09-28 2003-03-21 Polymer composition and dosage forms comprising the same

Publications (1)

Publication Number Publication Date
BR0314781A true BR0314781A (pt) 2005-07-26

Family

ID=34271652

Family Applications (5)

Application Number Title Priority Date Filing Date
BR0314777-0A BR0314777A (pt) 2002-09-28 2003-03-21 Formas de dosagem de liberação modificada
BR0314781-9A BR0314781A (pt) 2002-09-28 2003-03-21 Composição de polìmero e formas de dosagem compreendendo a mesma
BR0314787-8A BR0314787A (pt) 2002-09-28 2003-03-21 Forma de dosagem de liberação modificada
BR0314804-1A BR0314804A (pt) 2002-09-28 2003-03-21 Forma de dosagem de liberação modificada
BR0314547-6A BR0314547A (pt) 2002-09-28 2003-03-21 Forma de dosagem com liberação imediata compreendendo invólucro tendo aberturas no mesmo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR0314777-0A BR0314777A (pt) 2002-09-28 2003-03-21 Formas de dosagem de liberação modificada

Family Applications After (3)

Application Number Title Priority Date Filing Date
BR0314787-8A BR0314787A (pt) 2002-09-28 2003-03-21 Forma de dosagem de liberação modificada
BR0314804-1A BR0314804A (pt) 2002-09-28 2003-03-21 Forma de dosagem de liberação modificada
BR0314547-6A BR0314547A (pt) 2002-09-28 2003-03-21 Forma de dosagem com liberação imediata compreendendo invólucro tendo aberturas no mesmo

Country Status (8)

Country Link
JP (3) JP2006517514A (pt)
CN (3) CN1700908A (pt)
AT (1) ATE444739T1 (pt)
AU (4) AU2003220472A1 (pt)
BR (5) BR0314777A (pt)
CA (3) CA2500313C (pt)
DE (2) DE60329614D1 (pt)
MX (1) MXPA05003283A (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470463C (en) 2004-06-09 2012-09-18 Lornamead Brands, Inc. Tooth whitening products and methods of making the same
SA07280459B1 (ar) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
US20110195121A1 (en) * 2008-06-19 2011-08-11 Seshni Sewlall chronotherapeutic pharmaceutical dosage form
JPWO2011118454A1 (ja) * 2010-03-23 2013-07-04 リンテック株式会社 固形製剤
US9693957B2 (en) * 2011-07-08 2017-07-04 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
EP2811985B1 (en) * 2012-02-07 2018-10-17 Johnson & Johnson Consumer Inc. Rapidly disintegrating coated tablets
TW201400146A (zh) * 2012-06-05 2014-01-01 Takeda Pharmaceutical 有核錠
EP3193845A1 (en) * 2014-09-19 2017-07-26 The Procter and Gamble Company Pulsed release phenylephrine dosage forms
EP3731821A1 (en) * 2017-12-29 2020-11-04 Laxxon Medical AG Drug delivery system
AU2022320730A1 (en) * 2021-07-30 2024-03-14 Evecxia Therapeutics, Inc. 5-hydroxytryptophan gastroretentive dosage forms
CN115295864B (zh) * 2021-11-09 2023-08-11 深圳市德方创域新能源科技有限公司 正极补锂添加剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007470A1 (en) * 1992-09-30 1994-04-14 Pfizer Inc. Article containing a core and a coating having a non constant thickness
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
WO2001078681A1 (fr) * 2000-04-17 2001-10-25 Yamanouchi Pharmaceutical Co., Ltd. Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant
JP2004518708A (ja) * 2001-02-13 2004-06-24 アストラゼネカ・アクチエボラーグ 放出性が改良された新規な処方物

Also Published As

Publication number Publication date
AU2003220472A1 (en) 2004-04-19
BR0314787A (pt) 2005-07-26
CN1700908A (zh) 2005-11-23
MXPA05003283A (es) 2005-11-23
CA2500311A1 (en) 2004-04-08
BR0314547A (pt) 2005-08-09
CN1684671A (zh) 2005-10-19
BR0314804A (pt) 2005-08-02
CA2500312A1 (en) 2004-04-08
JP2006517183A (ja) 2006-07-20
BR0314777A (pt) 2005-07-26
DE60329614D1 (de) 2009-11-19
DE60335270D1 (de) 2011-01-20
AU2003220466A1 (en) 2004-04-19
JP2006517182A (ja) 2006-07-20
AU2003225944A1 (en) 2004-04-19
AU2003218359A1 (en) 2004-04-19
ATE444739T1 (de) 2009-10-15
JP2006517514A (ja) 2006-07-27
CN1700907A (zh) 2005-11-23
CA2500313A1 (en) 2004-04-08
CA2500313C (en) 2011-06-07

Similar Documents

Publication Publication Date Title
ATE551988T1 (de) Orale zusammensetzungen, ihre herstellung und verwendung
NO20051542L (no) Farmasoytisk preparat
BR0314781A (pt) Composição de polìmero e formas de dosagem compreendendo a mesma
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
CL2004000778A1 (es) Compuestos derivados de heterociclos de 5 miembros, inhibidores de la porteina tirosina fosfatasa 1b (ptp1b); composiciones farmaceuticas, utiles para tratar hipertension, obesidad, diabetes, hiperlipidemia.
EA200700658A1 (ru) Фармацевтическая композиция, представляющая собой твердую дисперсию с полимерной матрицей, содержащей непрерывную фазу полидекстрозы и непрерывную фазу полимера, не являющегося полидекстрозой
BRPI0715579A2 (pt) &#34;composto, composição farmacêutica e uso de um composto&#34;
BRPI0511966A (pt) composições farmacêuticas contendo polietileno glicol tendo um peso molecular menor do que 600 daltons
CL2004000270A1 (es) Compuestos derivados de pirazol, sus sales de adicion acidas,trastornos de vih y virus geneticamente relacionados. hidratos, solvatos; composiciones farmaceuticas; y su uso en el tramiento de trastornos del vih y virus geneticamente relacionados.
CL2004000590A1 (es) Compuestos derivados de 1,3,4-oxadiazol-3-ona, 1,3,4-tiadiazol-2-ona y de 1,2,4-triazol-3-ona; composicion farmaceutica que los contiene; procedimiento de preparacion y su uso en la preparacion de un medicamento en los que esta relacionado el virus v
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
RS51271B (sr) Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
UY29169A1 (es) Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica
TW200637584A (en) External skin agent for preventing inflammation
CL2003002611A1 (es) Compuestos derivados del acido tiofeno hidroxamico, 2-hidroxamida-5-[(aril o heteroaril)-disutituido-metil]-amida del acido tiofeno-2,5-dicarboxilico enantiomeros, composicion farmaceutica, procedimiento de preparacion, y su uso para el tratamiento d
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
HUP0101374A2 (hu) Szervetlen nitritet és szerves savat tartalmazó helyi vírusellenes készítmény
GB2421241A (en) Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
TW200630121A (en) Immediate release film coating
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
IS7492A (is) Lyfjablöndu uppskriftir, sem innifela melantónín

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]